WAVE THERAPEUTICS

Welcome to the Brand page for “WAVE THERAPEUTICS”, which is offered here for Nucleic acid sequences and chemical reagents for medical purposes; pharmaceutical preparations for the treatment of genetic diseases and disorders; nucleic acid therapeutic agents for the treatment of huntington's disease, duchenne muscular dystrophy and inflammatory bowel disease; nucleic acid therapeutic agents and pharmaceutical preparations for the prevention, treatment and diagnosis of neurodegenerative diseases, alzheimer's disease, parkinson's disease, and huntington's disease; pharmaceutical preparations for the prevention, treatment and diagnosis of immune disorders, psoriasis, rheumatoid arthritis, lupus, crohn's disease, inflammatory bowel disease, and multiple sclerosis; pharmaceutical preparations for diagnosis and treatment of viral, bacterial, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric and immune system related diseases and disorders;therapeutics;research and development in the fields of pharmaceuticals, genetics, therapeutics, and drug formulation and delivery; scientific research; scientific research in the fields of pharmaceuticals, medicine and nucleic acid therapeutics; research, development and testing services in the field of nucleic acid therapeutics for medical and scientific applications; medical research; laboratory research services relating to pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “WAVE THERAPEUTICS” is believed to be currently owned by “Wave Life Sciences Ltd.”